Respira Global Inc.

Respira Global Inc. is the exclusive North American distributor of HypoxBreath® Advanced, a European Union Class IIa certified medical device delivering precision-guided Intermittent Hypoxia-Hyperoxia Therapy (IHHT). We support the integration of advanced breath training into wellness, clinical, and performance environments across North America. Developed and regulated in the EU, HypoxBreath® is engineered to facilitate adaptive respiratory patterns using alternating oxygen protocols, real-time heart rate variability (HRV) biofeedback, and automated safety thresholds. It is utilized globally in applications focused on stress modulation, recovery, and physical resilience. Respira Global does not make specific therapeutic or medical claims and adheres to applicable regulatory frameworks in the United States. Our role is to provide access to sophisticated, non-invasive technology that supports professionals operating within their own scopes of practice. We serve healthcare practitioners, performance specialists, and wellness providers seeking to incorporate structured respiratory training systems rooted in biofeedback, individualized protocols, and emerging physiological science.